Related Experiment Video
Updated: May 3, 2026

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Serum brain-type creatine kinase increases in children with osteogenesis imperfecta during neridronate treatment
Patrizia D'Eufemia1, Roberto Finocchiaro1, Ciro Villani2
1Department of Pediatrics, "Sapienza", University of Rome, Rome, Italy.
Insights
Serum creatine kinase-brain isoform (Ckbb) levels increase during bisphosphonate treatment in children with osteogenesis imperfecta (OI). This suggests suppressed osteoclast activity, potentially aiding in preventing overtreatment in pediatric patients.
Area of Science:
- Biochemistry
- Pediatric Endocrinology
- Bone Biology
Background:
- Creatine kinase (Ck) facilitates energy transfer, with the brain isoform (Ckbb) crucial for osteoclast function in bone resorption.
- Elevated serum Ckbb is observed in osteopetrosis and bisphosphonate (BP)-induced conditions.
- Bisphosphonates (BPs) are standard treatment for osteogenesis imperfecta (OI), inhibiting bone resorption by osteoclasts.
Purpose of the Study:
- To investigate changes in serum total Ck and Ckbb activity in prepubertal children with type I OI undergoing bisphosphonate therapy.
- To assess the correlation between serum Ckbb levels and bone resorption markers during treatment.
Main Methods:
- Serum Ck and isoform activity were measured in 18 children with type I OI before and during neridronate infusions.
- Statistical analysis was performed to determine significant changes and correlations.
Main Results:
- Basal serum Ckbb levels were slightly elevated compared to controls.
- Serum Ckbb levels progressively increased after neridronate treatment, with significant increments observed after infusions.
- An inverse correlation was noted between basal serum Ckbb and serum CTx levels.
Conclusions:
- Increased serum Ckbb supports the hypothesis that it reflects osteoclast suppression or failure.
- The findings suggest that monitoring serum Ckbb could help prevent overtreatment with long-acting bisphosphonates in pediatric OI patients.
Background:
Creatine kinase (Ck) catalyzes the reversible transfer of high-energy phosphate groups between adenosine triphosphate and phosphocreatine. The brain isoform (Ckbb) is greatly induced in mature osteoclasts, playing an important role in bone-resorbing function during osteoclastogenesis. High Ckbb serum level has been found in patients with osteopetrosis and in patients with bisphosphonate (BP)-induced osteopetrosis. BPs are considered the treatment of choice for children with osteogenesis imperfecta (OI), acting as potent inhibitors of bone resorption by suppressing the activity of osteoclasts.
Methods:
We determined total serum Ck and isoform activity in 18 prepubertal children with type I OI, before and during treatment with the BP neridronate infusions.
Results:
Basal serum Ckbb levels were slightly elevated with respect to controls (mean ± SD = 3.0 ± 2.7 vs. 2.0 ± 2.2) and progressively increased after neridronate treatment (t0 vs. t4: mean ± SD = 3.0 ± 2.7 to 10.8 ± 8.1), with significant increment after first, second, and fourth infusions (P < 0.01). An inverse correlation was found between serum Ckbb and serum CTx at basal level.
Conclusion:
Our results support previous observations that increased serum Ckbb reflects failure of osteoclasts or, at least, suppression of osteoclasts. Upon considering that BPs are long acting, this information could be useful to prevent the risk of overtreatment after long-term BP exposure in pediatric patients with OI.
More Related Videos
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Related Concept Videos
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...